Increased expression of neutral endopeptidase (NEP) and aminopeptidase N (APN) on peripheral blood mononuclear cells in patients with multiple sclerosis

Immunology Letters

Volumn 71, Issue 2, 2000, Pages 127-129

  Ziaber, J ^a   Baj, Z ^b   Pasnik J ^b   Chmielewski, H ^a   Tchorzewski H ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b D P M M A   (Poland)

^c D C I I of Pol Mother's Hlth   (Poland)

Author keywords

APN; Lymphocytes; Metalloproteinases; Monocytes; Multiple sclerosis; NEP

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL MIGRATION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE EXACERBATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD13; CASE-CONTROL STUDIES; CELL MEMBRANE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; NEPRILYSIN;

EID: 0034141665     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(99)00176-5     Document Type: Article

References (15)

1. Giovannoni G., Hartung H.P. The immunopathogenesis of multiple sclerosis and Guillaine-Barre syndrome. Curr. Opin. Neurol. 9:1996;165-177.
2. Hohlfeld R., Meinl E., Weber F., Zipp F., Schmidt S., Sotgiu S. et al. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology. 45(suppl. 6):1995;S33-S38.
3. Wucherpfennig K.W., Zhang J., Witek C., Matsui M., Modabber Y., Ota K. et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152:1994;5581-5592.
4. Opdenakker G., Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol. Today. 15:1994;103-107.
5. Constantinescu C.S., Kamoun M., Dotti M., Farber R.E., Galetta S.L., Rostami A. A longitudinal study of the T cell activation marker CD26 in chronic progressive multiple sclerosis. J. Neurol. Sci. 130:1995;178-182.
6. Poser C.M., Paty D.W., Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1993;227-231.
7. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
8. Rawlings N.D., Barrett A.J. Evolutionary families of metallopeptidases. Methods Enzymol. 248:1995;183-228.
9. Lichtinghagen R., Seifert T., Kracke A., Marckmann S., Wurster U., Heidenreich F. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J. Neuroimmunol. 99:1999;19-26.
10. Kenny J. Cell surface peptidases are neither peptide nor organ specific. Trends Biochem. Sci. 11:1986;40-45.
11. Saiki I., Yoneda J., Abe F., Nakajima M., Tsuruo T., Azuma I. Role of aminopeptidase N (CD13) in tumor cell invasion and extracellular matrix degradation. Int. J. Cancer. 54:1993;137-143.
12. Riemann D., Kehlen A., Thiele K., Lohn M., Langner J. Induction of aminopeptidase N /CD13 on human lymphocytes after adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells, and monocytes/macrophages. J. Immunol. 158:1997;3425-3432.
13. Malfroy B., Kuang W., Seeburg P.S., Mason A.J., Schofield P.R. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett. 229:1988;206-210.
14. Hoffmann T., Faust J., Neubert K., Ansorge S. Dipeptydyl peptidase IV (CD26) and aminopeptidase N (CD13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 336:1993;61-64.
15. Kondepudi A., Johnson A. Cytokines increase neutral endopeptidase activity in lung fibroblast. Am. J. Respir. Cell Mol. Biol. 8:1993;43-47.